- Home
- BQ vs INM Comparison
BQ vs INM Comparison
Compare BQ & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BQ | INM |
|---|---|---|
| Founded | 2008 | 1981 |
| Country | China | Canada |
| Employees | N/A | 6 |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7M | 8.8M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BQ | INM |
|---|---|---|
| Price | $0.50 | $1.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 37.1K | ★ 48.3K |
| Earning Date | 07-13-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 62.68 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,942,633.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $26.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.50 |
| 52 Week Low | $0.45 | $0.58 |
| 52 Week High | $4.05 | $2.33 |
Technical Indicators
Market Signals| Indicator | BQ | INM |
|---|---|---|
| Relative Strength Index (RSI) | 20.15 | 69.26 |
| Support Level | $0.45 | $1.45 |
| Resistance Level | $0.89 | $1.68 |
| Average True Range (ATR) | 0.05 | 0.09 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 11.99 | 81.08 |
Price Performance
Historical ComparisonAbout BQ Boqii Holding Limited representing
Boqii Holding Ltd is a pet-focused platform in China. It offer a truly one-stop destination that pet parents in China may go to get everything it need for their pets and share their passion for pet parenting. It operate a pet-focused online retail business in China's pet market in terms of GMV. The company operates in single segment. This segment is engaged in pet products sales and online marketing and information services and other. All the company's revenues is derived from The PRC.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.